Distribution of Syncopal Eventsfor all UprimaŽ Studies
Dose
Fixed Dose
Dose-Optimization
2 mg 0.2% (2/964) N/A
4 mg 1.2% (7/590) 0.6% (4/690)
5 mg 0.8% (7/860) 1.1% (6/556)
6 mg 2.1% (13/621) 0.3% (2/631)
Recommended Doses
Higher Than Recommended Doses
Safety-Syncope
Previous slide
Next slide
Back to first slide
View graphic version